Scientific Diligence
Know what is real, what is differentiated, and what still has to be proven.
- A scientific and technical thesis
- An evidence and risk assessment
- A go, reshape, or stop call
For investors, inventors, and TTOs
Discuss an opportunityScientific strategy and development
Turn promising science into a program built to advance.
Moeda helps biotechnology companies define the opportunity, develop the product, and lead the scientific work required to move it forward.
Services
Decide. Build. Translate.
Program Strategy & Leadership
Turn promising science into a focused plan, and lead the science that executes it.
- A product definition and roadmap
- A proof-of-concept and experimental plan
- Ongoing scientific leadership through execution
For teams needing scientific leadership
Translation & Scale-Up
Build the evidence, process, and development package needed to advance.
- Preclinical and IND-enabling studies
- Process development and scale-up
- Technology transfer and CMC strategy
For programs approaching the clinic
Capabilities
The full range of work.
Define
- Opportunity and landscape assessment
- Scientific differentiation
- Evidence and risk analysis
- Product and program definition
Develop
- Formulation and process development
- Assay and model selection
- Proof-of-concept studies
- Experimental strategy
Advance
- Preclinical development
- IND-enabling strategy and studies
- Process optimization and scale-up
- Technology transfer and CMC
Client perspective
From an idea to something buildable.
“Moe helped us go from a broad idea to something we could actually build. He clarified the opportunity, what could make it different, and the evidence we would need to support it.”
Founder-led scientific leadership
Dr. Moe Wehbe, Ph.D.
Founder, Moeda Consulting Corp.
Dr. Moe Wehbe is a pharmaceutical scientist and platform builder with deep expertise in drug delivery across modalities. He holds a Ph.D. in Pharmaceutical Sciences from the University of British Columbia.
Moe began in academic drug delivery research at UBC, where he co-invented a platform technology, and completed postdoctoral training in immuno-engineering and polymer nanoparticles at Vanderbilt University.
He went on to serve as a process development scientist at ReCode Therapeutics and a founding scientist at Mirai Bio in the Flagship Pioneering ecosystem, building and advancing extrahepatic LNP platforms from proof of concept through NHP-ready batches and GMP CDMO transfer.
Moe founded Moeda Consulting Corp. to give founders, investors, technology transfer offices, and biotechnology teams access to experienced scientific leadership at the moments it matters most.
Start a conversation
What are you trying to build?
Tell us where the program stands and the decision or milestone ahead.
Helpful context
- Company or opportunity stage
- The scientific or technical challenge
- The next milestone that matters